Results 211 to 220 of about 27,659 (257)
Some of the next articles are maybe not open access.
Molecular Analyses of Oral Polio Vaccine Samples
Science, 2001It has been suggested that the human immunodeficiency virus (HIV), and thus the acquired immunodeficiency syndrome (AIDS) it causes, was inadvertently introduced to humans by the use of an oral polio vaccine (OPV) during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959.
H, Poinar, M, Kuch, S, Pääbo
openaire +2 more sources
Paralytic Disease Associated With Oral Polio Vaccines
JAMA, 1964SINCE 1961 when the oral poliomyelitis vaccines were first made available for general use in the United States, scattered cases of paralytic disease have occurred in association with these vaccines. Many of the cases have been clinically indistinguishable from poliomyelitis.
D A, HENDERSON +3 more
openaire +2 more sources
The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox
Vaccine, 2010This literature review identifies the factors that influence the decision to introduce inactivated polio vaccine (IPV) in developing countries as opposed to the policy of vaccine cessation. Attenuated viruses in the oral polio vaccine (OPV) can replicate, revert to neurovirulence and become transmissible circulating vaccine-derived polioviruses (cVDPVs)
Heinsbroek, E., Ruitenberg, E.J.
openaire +3 more sources
Use of oral polio vaccine for polio eradication.
Journal of the Indian Medical Association, 2006The experience in three of the world's six WHO Regions (the Americas, the European and the Western Pacific Regions) shows that OPV is the right choice for stopping wild poliovirus transmission. Polio can be eradicated by carrying out SIAs to supplement routine vaccination and by placing added emphasis on reaching every child during every polio round ...
Pankaj, Bhatnagar +2 more
openaire +1 more source
Health insurance status and cancer stage at diagnosis and survival in the United States
Ca-A Cancer Journal for Clinicians, 2022Jingxuan Zhao +2 more
exaly

